ARL6 (N-Term) Antikörper

Antigen: ARL6

Epitope: N-Term

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human

Applikation: Western Blot (WB), Immunhistochemie (IHC), ELISA

Zertifikate: ISO 9001:2008

Produktnummer: ABIN389005

Produktbeschreibung

Produktmerkmale: Purified Rabbit Polyclonal Antibody (Pab)

Weitere Bezeichnung: ARL6 (N-term)

Gen-ID: 84100

Swiss-Prot: ARL6_HUMAN

Immunogen: This ARL6 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1~30 amino acids from the N-terminal region of human ARL6.

Isotyp: Ig  (Passende Sekundärantikörper)

Beschreibung: Other names: ADP-ribosylation factor-like protein 6

Spezifität: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human ARL6.

Molekulargewicht: 21097 DA

Anwendungen

Applikationshinweise: The suggested dilution is: ELISA~~1:1,000 Western blot~~1:100~500 Immunohistochemistry~~1:50~100

Konzentration: 0.25 mg/ml

Reinigung: Purified

Buffer: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.

Lagerung: Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles

Forschungsgebiet: Zelluläre Signaltransduktion, Proteinmodifikationen, Zellstruktur

Beschränkungen: Nur für Forschungszwecke einsetzbar

Bilder

Western blot analysis of hARL6-M1 (Cat. #ABIN389005) in HL-60 cell line lysates (35ug/lane). ARL6 (arrow) was detected using the purified Pab. Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry, clinical relevance has not been evaluated. BC = breast carcinoma, HC = hepatocarcinoma.

anti-ARL6 (N-Term) antibody (Image 2)

Publikationen

Publikationen: Wiens, Tong, Esmail et al.: "The Bardet-Biedl syndrome-associated small GTPase ARL6 (BBS3) functions at or near the ciliary gate and modulates Wnt signalling." in: The Journal of biological chemistry, 2010 (PubMed).